Back to Journals » Neuropsychiatric Disease and Treatment » Volume 13

Suicidal and homicidal tendencies after Lyme disease: an ignored problem

Authors Munir A, Aadil M, Rehan Khan A

Received 2 July 2017

Accepted for publication 5 July 2017

Published 2 August 2017 Volume 2017:13 Pages 2069—2071


Checked for plagiarism Yes

Editor who approved publication: Dr Roger Pinder

Aitzaz Munir,1 Muhammad Aadil,2 Ahmad Rehan Khan3

1Department of Psychiatry, Howard University, Washington, DC, USA; 2Department of Psychiatry, Rush University Medical Center, Chicago, IL, USA; 3Department of Psychiatry, University of North Dakota, Grand Forks, ND, USA
We would like to applaud the author for conducting such an important study by performing a comprehensive assessment of suicide and its association with Lyme-associated diseases (LADs).1 It is the first study of its kind, and it raises a need for further investigation on this subject. Suicide is a major health care issue in the USA, contributing to almost 42,773 deaths in the USA in 2014.2 There is no data available specific to suicide associated with LAD. Dr Bransfield inferred the possible prevalence of suicide associated with LAD by an indirect method which revealed that 414,540 patients with LAD have suicidal ideation, 31,100 attempt suicide and a total of 1,244 commit suicide in the USA per year from LAD.1,2 
Author’s reply
Robert C Bransfield

Department of Psychiatry, Rutgers-RWJ Medical School, Piscataway, NJ, USA 

I would like to thank Munir, Aadil, and Khan for their insightful letter identifying necessary future directions. They recognize the value of accurate and early diagnosis of Lyme and associated diseases (LADs), the value of individualized treatment that includes both antibiotics and traditional psychiatric treatments and future epidemiological and research directions. These efforts could help prevent many tragic suicides. Suicidal and homicidal tendencies after Lyme disease are clearly an ignored problem that deserves greater attention.

View the original paper by Bransfield.

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]